fbpx
Size of letters 1x
Site color
Image
Additionally
Line height
Letter spacing
Font
Embedded items (videos, maps, etc.)
 

Baker McKenzie advised on the sale of the Ukrainian laboratory operations of Invitro

26/ 11/ 2018
  Kyiv, Ukraine, 26 November 2018. Baker McKenzie advised Invitro on the sale of its Ukrainian laboratory operations to Medicover. The deal was signed on 17 October 2018. The operations consist of about 60 blood-drawing points (BDPs) and one laboratory, focused on eastern and central Ukraine. The transaction is expected to be closed in early 2019. The transaction is subject to customary regulatory approvals. Baker McKenzies team was led by Olha Demianiuk, Partner in the Baker McKenzies Kyiv office and Dmitry Yeremin, Counsel in the Moscow office of Baker McKenzie. About Invitro  INVITRO is the largest private medical company in Russia, which specializes in high-precision medical diagnostics and the provision of medical services. Founded in 1995, today INVITRO has the largest network of medical offices in Eastern Europe, operating nine modern laboratories in six countries. INVITRO offers more than 1,800 types of laboratory researches and instrumental and computer diagnostic services, effectively helping doctors and patients take care of their health throughout their lives. About Medicover  Medicover is a leading international healthcare and diagnostic services provider. Established in 1995 in response to the growing demand for high-quality healthcare services in Poland, Medicover subsequently expanded to other countries fulfilling similar needs. Today, Medicover’s largest operations are in Germany, Poland, Romania and Ukraine. Medicover provides a broad spectrum of healthcare services via an extensive network of ambulatory clinics, hospitals, specialty-care facilities and laboratories through two divisions – Healthcare Services and Diagnostic Services. About Baker McKenzie Baker McKenzie helps clients overcome the challenges of competing in the global economy. We solve complex legal problems across borders and practice areas. Our unique culture, developed over 65 years, enables our 13,000 people to understand local markets and navigate multiple jurisdictions, working together as trusted colleagues and friends to instil confidence in our clients. (www.bakermckenzie.com) For more information, please contact: Oksana Kozhukhivska Marketing and PR Manager Baker McKenzie +380 44 590 0101 oksana.kozhukhivska@bakermckenzie.com

Kyiv, Ukraine, 26 November 2018. Baker McKenzie advised Invitro on the sale of it’s Ukrainian laboratory operations to Medicover. The deal was signed on 17 October 2018.

The operations consist of about 60 blood-drawing points (BDPs) and one laboratory, focused on eastern and central Ukraine. The transaction is expected to be closed in early 2019. The transaction is subject to customary regulatory approvals.

Baker McKenzie’s team was led by Olha Demianiuk, Partner in the Baker McKenzie’s Kyiv office and Dmitry Yeremin, Counsel in the Moscow office of Baker McKenzie.


About Invitro 

INVITRO is the largest private medical company in Russia, which specializes in high-precision medical diagnostics and the provision of medical services. Founded in 1995, today INVITRO has the largest network of medical offices in Eastern Europe, operating nine modern laboratories in six countries. INVITRO offers more than 1,800 types of laboratory researches and instrumental and computer diagnostic services, effectively helping doctors and patients take care of their health throughout their lives.

About Medicover 

Medicover is a leading international healthcare and diagnostic services provider. Established in 1995 in response to the growing demand for high-quality healthcare services in Poland, Medicover subsequently expanded to other countries fulfilling similar needs. Today, Medicover’s largest operations are in Germany, Poland, Romania and Ukraine. Medicover provides a broad spectrum of healthcare services via an extensive network of ambulatory clinics, hospitals, specialty-care facilities and laboratories through two divisions – Healthcare Services and Diagnostic Services.

About Baker McKenzie

Baker McKenzie helps clients overcome the challenges of competing in the global economy. We solve complex legal problems across borders and practice areas. Our unique culture, developed over 65 years, enables our 13,000 people to understand local markets and navigate multiple jurisdictions, working together as trusted colleagues and friends to instil confidence in our clients. (www.bakermckenzie.com)

For more information, please contact:

Oksana Kozhukhivska

Marketing and PR Manager
Baker McKenzie
+380 44 590 0101
oksana.kozhukhivska@bakermckenzie.com

If you have found a spelling error, please, notify us by selecting that text and pressing Ctrl+Enter.

Start
in the Telegram bot
Read articles. Share in social networks
0 Shares

Spelling error report

The following text will be sent to our editors: